Pattern of Thyroid Cancer in the Eastern Province of Saudi Arabia: University Hospital Experience


Objectives: To review the pattern of thyroid tumor, demographic data of the patients, sensitivity, and specificity of fine needle aspiration cytology; Materials and Methods: This is a retrospective analysis of patients who underwent total or near-total thyroidectomy at King Fahad Hospital of the University between 1982 and 2008. Data were analyzed for demographic characteristics, type of thyroid tumors, Fine Needle Aspirations Cytology (FNAC) yields and surgical complications; Results: A total of 143 patients with thyroid tumors underwent throidectomy. Their median age was 37.5 years. Females were predominantly affected (81%) with female to male ratio of (4:29). Thyroid carcinoma accounted for (75%) while benign tumors for (25%). The most common thyroid epithelial cancer was papillary type (74%) and was limited to thyroid tissues in almost two third of cases. Non-epithelial cancer in the form of thyroid lymphoma accounted for (4.89%) of the cases. FNAC sensitivity was 56% and specificity 92%. Surgical complications occurred in 18% of the patients; Conclusions: The commonest malignant thyroid cancer was papillary carcinoma. Thyroid cancer was more common in females. FNAC is highly accurate to confirm thyroid cancer but less sensitive in this study. Surgical complications were relatively minimal.

Share and Cite:

A. M. Al-Amri, "Pattern of Thyroid Cancer in the Eastern Province of Saudi Arabia: University Hospital Experience," Journal of Cancer Therapy, Vol. 3 No. 3, 2012, pp. 187-191. doi: 10.4236/jct.2012.33027.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Kingdom of Saudi Arabia, Ministry of Health, National Cancer Registry, “Cancer Incidence Report. 1999-2000,” 2004.
[2] T. T. Htwe, M. M. Hamdi, G. K. Swethadri, J. O. L. Wong, M. M. Soe and M. S. Abdullah, “Incidence of Thyroid Malignancy among Goitrous Thyroid Lesions from the Sarawak General Hospital,” Singapore Medical Journal, Vol. 50, No. 7, 2009, pp. 724-728.
[3] S. S. Al Sobhi, “The Current Pattern of Thyroid Surgery in Saudi Arabia and How to Improve It,” Annals of Saudi Medicine, Vol. 22, No. 3-4, 2002, pp. 3-4.
[4] D. S. Ross, “Predicting Thyroid Malignancy,” The Journal of Clinical Endocrinology & Metabolism, Vol. 91, No. 11, 2006, pp. 4253-4255. doi:10.1210/jc.2006-1772
[5] E. L. Mazzaferri, “Thyroid Cancer in Thyroid Nodules: Finding a Needle in the Haystack,” The American Journal of Medicine, Vol. 93, No. 4, 1992, pp. 359-362. doi:10.1016/0002-9343(92)90163-6
[6] A. S. Irshad, M. Girivasan, V. Ramesh and J. A. Santhosh, “High Incidence of Thyroid Cancer in Toxic Multinodular Goiters,” Asian Pacific Journal of Clinical Oncology, Vol. 3, No. 3, 2007, pp. 119-124. doi:10.1111/j.1743-7563.2007.00108.x
[7] A. Belfiore, G. L. La Rosa, G. A. La Porta, D. Giuffrida, G. Millazo, L. Lupo, et al., “Cancer Risk in Patients with Cold Thyroid Nodules: Relevance of Iodine Intake, Sex, Age, and Multinodularity,” The American Journal of Medicine, Vol. 93, No. 4, 1992, pp. 363-369. doi:10.1016/0002-9343(92)90164-7
[8] R. A. Delellis, “Pathology and Genetics of Thyroid Carcinoma,” Journal of Surgical Oncology, Vol. 94, No. 8, 2006, pp. 662-669. doi:10.1002/jso.20700
[9] P. Nix, A. Nicolides and A. P. Coatesworth, “Thyroid Cancer Review 1: Presentation and Investigation of Thyroid Cancer,” International Journal of Clinical Practice, Vol. 59, No. 11, 2005, pp. 1340-1344. doi:10.1111/j.1368-5031.2005.00671.x
[10] J. Christine, J. Oucharek, D. Learoyd and B. Stan, “Standarad and Emerging Therapies for Metastastic Differentiated Thyroid Cancer,” The Oncologist, Vol. 15, No. 2, 2010, pp. 146-156. doi:10.1634/theoncologist.2009-0190
[11] R. A. Delellis, R. V. Lloyd, P. U. Heitz and C. Eng, “Pathology and Genetics of Thyroid Carcinoma,” In: R. A. De-Lellis, Ed., Pathology and Genetics of Tumors of Endocrine Organs, IARC Press, Lyon, 2004, pp. 57-66.
[12] F. A. Qari, “Pattern of Thyroid Malignancy at a University Hospital in Western Saudi Arabia,” Saudi Medical Journal, Vol. 25, No. 7, 2004, pp. 447-451.
[13] M. Al-Jaradi, A. Sllam, H. Jabr, A. Borda, M. Decaussin-Petruci and N. Berger, “Prevalence of Differentiated Thyroid Cancer in 810 Cases of Surgically Treated Goiter in Yemen,” Annals of Saudi Medicine, Vol. 25, No. 5, 2005, pp. 394-397.
[14] Y. A. Abdulmughni, M. A. Al-Hureibi, K. A. Al-Hureibi, M. A. Ghafoor, A. H. Al-Wadan and Y. A. Al-Hureibi, “Thyroid Cancer in Yemen,” Saudi Medical Journal, Vol. 25, No. 1, 2004, pp. 55-59.
[15] S. M. Alsalamah, K. Khalid and H. A. Bismar, “Incidence of Differentiated Cancer in Nodular Goiter,” Saudi Medical Journal, Vol. 23, No. 8, 2002, pp. 947-952.
[16] J. K. Chan and D. Saw, “The Grooved Nucleus. A Useful Diagnostic Criterion of Papillary Carcinoma of the Thyroid,” American Journal of Surgical Pathology, Vol. 10, No. 10, 1986, pp. 672-629. doi:10.1097/00000478-198610000-00002
[17] C. D. Scopa, “Histopathology of Thyroid Tumors. An Overview,” HORMONES, Vol. 3, No. 2, 2004, pp. 100-110.
[18] E. Tuncel, C. Ersoy, E. Erturk and S. Imamoglu, “Retrospective Analysis of Histopathological Pattern of Thyroid Cancer in Southern Maramara Region of Turkey and Comparison of the Data of Previous Decade,” Turkish Journal of Endocrinology and Metabolism, Vol. 2003, No. 3, pp. 107-111.
[19] H. B. Burch, “Evaluation and Management of Solid Thyroid Nodule,” Endocrinology Metabolism Clinics of North America, Vol. 24, No. 4, 1995, pp. 663-710.
[20] N. Hussain, M. Anwar, N. Nadia and Z. Ali, “Pattern of Surgically Treated Thyroid Diseases in Karachi,” Biomedica, Vol. 21, 2005, pp. 18-20.
[21] Y. A. Abdul Mughni, M. A. Al-Hureibi, K. A. Al-Huriebi, M. A. Ghafoor, A. H. Al-Wadan and Y. A. Al-Hureibi, “Thyroid Cancer in Yemen,” Saudi Medical Journal, Vol. 25, No. 1, 2004, pp. 55-59.
[22] A. Z. Khan, S. A. Naqi, A. Kamal and K. J. Abaid, “Thyroidectomy in Carcinoma of Thyroid, a THREE Years Experience,” Annals, Vol. 10, No. 4, 2004, pp. 368-369.
[23] A. Elhamel, I. H. Sharif and S. A. Wassef, “The Pattern of Thyroid Disease in a Closed Community of 1-1/2 Million People,” Saudi Medical Journal, Vol. 9, No. 5, 1988, pp. 481-484.
[24] M. Ahmad, B. Al Saihati, W. Greer, A. Al-Nuaim, S. Bakheet, A. M. Abdulkareem, et al., “A Study of 875 Cases of Thyroid Cancer Observed over a Fifteen-Year Period (1975-89) at the King Faisal Specialist Hospital and Research Centre,” Annals of Saudi Medicine, Vol. 15, 1995, pp. 579-584.
[25] D. Sarne and A. B. Schneider, “External Radiation and Thyroid Neoplasia,” Endocrinology & Metabolism Clinics of North America, Vol. 25, No. 1, 1996, pp. 181-195. doi:10.1016/S0889-8529(05)70318-2
[26] S. A. Hundahl, B. Cady, M. P. Cunningham, E. Mazzaferri, R. F. Mckee, J. Rosai, et al., “Initial Results from a Prospective Cohort Study of 5583 Cases of Thyroid Carcinoma Treated in the United States during 1996. US and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patients Evaluation Study,” Cancer, Vol. 89, No. 1, 2000, pp. 202-217. doi:10.1002/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A
[27] C. Freeman, J. W. Berg and S. J. Cutler, “Occurrence and Prognosis of Extra-Nodal Lymphoma,” Cancer, Vol. 29, No. 1, 1972, pp. 252-260. doi:10.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#
[28] C. Thieblemont, A. Mayer, C. Dumontet, E. Barbier, P. Callet-Bauchu, F. Felman, et al., “Primary Thyroid Lymphoma Is Heterogeneous Disease,” The Journal of Clinical Endocrinology & Metabolism, Vol. 87, No. 1, 2002, pp. 105-111. doi:10.1210/jc.87.1.105
[29] V. A. Livolsi, K. Montone and M. Sack, “Pathology of Thyroid Gland,” In: S. S. Sternberg, Ed., Diagnostic Surgical Pathology, Lipincott Williams and Wilkins, Philadelphia, 1999, pp. 529-587.
[30] J. Cap, A. Ryska, P. Rehorkova, E. Hovorkova, Z. Kerekes and D. Pohnetalova, “Sensitivity and Specificity of the Fine Needle Aspiration Biopsy of the Thyroid. Clinical Point of View,” Clinical Endocrinology (Oxford), Vol. 51, No. 4, 1999, pp. 509-515. doi:10.1046/j.1365-2265.1999.00847.x
[31] J. M. Miller, J. I. Hamburger and S. Kini, “Diagnosis of Thyroid Nodules: Use of Fine Needle Aspiration and Needle Biopsy,” The Journal of the American Medical Association, Vol. 241, No. 5, 1979, pp. 481-484. doi:10.1001/jama.1979.03290310021006
[32] R. D. Bapat, S. H. Shah, R. G. Relekar, A. Pandit and S. D. Bhandarka, “Analysis of 105 Uninodular Goitres,” Journal of Postgraduate Medicine, Vol. 3, No. 2, 1992, pp. 60-61.
[33] W. C. Pederson, C. L. Johson, H. V. Gaskill III, J. B. Aust and A. B. Cruz Jr., “Operative Management of Thyroid Disease,” The American Journal of Surgery, Vol. 148, No. 3, 1984, pp. 350-352. doi:10.1016/0002-9610(84)90469-0
[34] J. Herranz-Gonzalez, J. Gavilan, J. Martinez-Vidal and C. Gavilan, “Complications following Thyroid Surgery,” Archives of Otolaryngology—Head & Neck Surgery, Vol. 117, No. 5, 1991, pp. 516-518. doi:10.1001/archotol.1991.01870170062014
[35] J. C. Filho and L. P. Kowalski, “Postoperative Complications of Thyroidectomy for Differentiated Thyroid Carcinoma,” American Journal of Otolaryngology—Head and Neck Medicine and Surgery, Vol. 25, No. 4, 2004, pp. 225-230. doi:10.1016/j.amjoto.2004.02.001

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.